{"product_id":"anti-pan-filovirus-gp-envelope-glycoprotein-recombinant-antibody-m21d10","title":"Anti-pan-Filovirus GP\/Envelope glycoprotein Recombinant Antibody (m21D10)","description":"\u003cp\u003e\u003cb\u003eSize\u003c\/b\u003e:100ug\u003c\/p\u003e\u003cp\u003e\u003cb\u003eDescription\u003c\/b\u003e:\u003c\/p\u003e\u003cp\u003e\u003cb\u003eHost species\u003c\/b\u003e:Human\u003c\/p\u003e\u003cp\u003e\u003cb\u003eSpecies reactivity\u003c\/b\u003e:Zaire Ebola virus (ZEBOV), Sudan Ebolavirus (SEBOV\/SUDV), Marburg virus (MARV)\u003c\/p\u003e\u003cp\u003e\u003cb\u003eForm\u003c\/b\u003e:Liquid\u003c\/p\u003e\u003cp\u003e\u003cb\u003eStorage buffer\u003c\/b\u003e:0.01M PBS pH 7.4\u003c\/p\u003e\u003cp\u003e\u003cb\u003ePurity\u003c\/b\u003e:\u0026gt;95% as determined by SDS-PAGE.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eClonality\u003c\/b\u003e:Monoclonal\u003c\/p\u003e\u003cp\u003e\u003cb\u003eIsotype\u003c\/b\u003e:IgG1, kappa\u003c\/p\u003e\u003cp\u003e\u003cb\u003eApplications\u003c\/b\u003e:ELISA, WB\u003c\/p\u003e\u003cp\u003e\u003cb\u003eTarget\u003c\/b\u003e:RecName: Full=Envelope glycoprotein; AltName: Full=GP1,2; Short=GP; Contains: RecName: Full=Shed GP; AltName: Full=GP1,2-delta; Contains: RecName: Full=GP1; Contains: RecName: Full=GP2; Flags: Precursor, GP, GP1,2, \/evidence=ECO:0000255., Filovirus glycoprotein; pfam01611, Envelope glycoprotein. \/id=PRO_0000037485., Extracellular. \/evidence=ECO:0000255., Shed GP. \/id=PRO_0000445686., GP1. \/id=PRO_0000037486., \/evidence=ECO:0007829|PDB:6HS4., N-\u0026gt;D: Induces GP1 secretion. Complete loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:6HS4., Interchain (between GP1 and GP2 chains). \/evidence=ECO:0000269|PubMed:12438572., \/evidence=ECO:0007829|PDB:6QD7., C-\u0026gt;G: Induces GP1 secretion. Complete loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., Receptor-binding. \/evidence=ECO:0000255., D-\u0026gt;A: 80% loss of virus capability to enter into host cell., D-\u0026gt;E,K: No effect on viral entry., Involved in receptor recognition and\/or post-binding events. \/evidence=ECO:0000255., L-\u0026gt;A: Complete loss of virus capability to enter into host cell., L-\u0026gt;F,I,K: 90% loss of virus capability to enter into host cell., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:6HS4., Involved in receptor recognition and\/or post-binding events. \/evidence=ECO:0000255., L-\u0026gt;A: 90% loss of virus capability to enter into host cell., L-\u0026gt;F: Almost complete loss of virus capability to enter into host cell., L-\u0026gt;K: Complete loss of virus capability to enter into host cell., Involved in receptor recognition and\/or post-binding events. \/evidence=ECO:0000255., R-\u0026gt;A,E: Complete loss of virus capability to enter into host cell., R-\u0026gt;K: No loss of virus capability to enter into host cell., S -\u0026gt; P (in strain: Isolate mouse-adapted)., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:6HS4., F-\u0026gt;A,E: Complete loss of virus capability to enter into host cell., F-\u0026gt;A: About 50% loss of ability to counteract host BST2. \/evidence=ECO:0000269|PubMed:27707924., F-\u0026gt;I: No loss of virus capability to enter into host cell., Involved in receptor recognition and\/or post-binding events. \/evidence=ECO:0000255., Involved in receptor recognition and\/or post-binding events. \/evidence=ECO:0000255., K-\u0026gt;A,E: 80% loss of virus capability to enter into host cell., K-\u0026gt;R: 20% loss of virus capability to enter into host cell., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0000255., C-\u0026gt;G: Almost complete loss of expression of GP1 and GP2. Almost complete loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., L-\u0026gt;A: About 60% loss of ability to counteract host BST2. \/evidence=ECO:0000269|PubMed:27707924., \/evidence=ECO:0007829|PDB:9BSV., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0000255., C-\u0026gt;G: Reduced levels of expression of GP1 and GP2. 50% loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., L-\u0026gt;A: About 60% loss of ability to counteract host BST2. \/evidence=ECO:0000269|PubMed:27707924., \/evidence=ECO:0007829|PDB:6HS4., C-\u0026gt;S: Almost complete loss of expression of GP1 and GP2. Complete loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., C-\u0026gt;S: Reduced levels of expression of GP1 and GP2. Almost complete loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:6HS4., I-\u0026gt;A: 90% loss of virus capability to enter into host cell., I-\u0026gt;E: Complete loss of virus capability to enter into host cell., I-\u0026gt;F: 50% loss of virus capability to enter into host cell., Involved in receptor recognition and\/or post-binding events. \/evidence=ECO:0000255., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:7JPI., \/evidence=ECO:0007829|PDB:7JPI., N-\u0026gt;D: No effect on GP1 and GP2 expression. No loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:6HS4., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., \/evidence=ECO:0007829|PDB:6HS4., N-\u0026gt;Y: No effect on GP1 and GP2 expression. 12% loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., \/evidence=ECO:0007829|PDB:6HS4., S -\u0026gt; P (in strain: Isolate mouse-adapted)., \/evidence=ECO:0007829|PDB:6HS4., N-\u0026gt;D: No effect on GP1 and GP2 expression. 12% loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:6HS4., N-\u0026gt;D: No effect on GP1 and GP2 expression. 18% loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., \/evidence=ECO:0007829|PDB:7TN9., Mucin-like region., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:7LYD., Disordered. \/evidence=ECO:0000256|SAM:MobiDB-lite., Polar residues. \/evidence=ECO:0000256|SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., invasion associated endopeptidase, N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., Disordered. \/evidence=ECO:0000256|SAM:MobiDB-lite., Polar residues. \/evidence=ECO:0000256|SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., Disordered. \/evidence=ECO:0000256|SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., Low complexity. \/evidence=ECO:0000256|SAM:MobiDB-lite., Polar residues. \/evidence=ECO:0000256|SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., RRTRR-\u0026gt;AGTAA: Almost complete loss of cleavage between GP1 and GP2. No loss of infectivity. \/evidence=ECO:0000269|PubMed:11152533., RTRR-\u0026gt;ATAA: No effect on cleavage between GP1 and GP2. \/evidence=ECO:0000269|PubMed:9882347., Cleavage; by host furin. \/evidence=ECO:0000269|PubMed:9576958., GP2. \/id=PRO_0000037487., \/evidence=ECO:0000255., C-\u0026gt;G: Induces GP1 secretion. Complete loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:8DPM., Fusion peptide. \/evidence=ECO:0000305., \/evidence=ECO:0007829|PDB:6HS4., G-\u0026gt;R: Reduced infectivity. \/evidence=ECO:0000269|PubMed:10482652., L-\u0026gt;A,R: Reduced infectivity. \/evidence=ECO:0000269|PubMed:10482652., I-\u0026gt;A: Reduced infectivity. \/evidence=ECO:0000269|PubMed:10482652., I-\u0026gt;R: Almost complete loss of infectivity. No effect on transport of GP to the cell surface and incorporation onto virions. \/evidence=ECO:0000269|PubMed:10482652., \/evidence=ECO:0007829|PDB:6HS4., F-\u0026gt;A: Reduced infectivity. \/evidence=ECO:0000269|PubMed:10482652., F-\u0026gt;R: Almost complete loss of infectivity. No effect on transport of GP to the cell surface and incorporation onto virions. \/evidence=ECO:0000269|PubMed:10482652., G-\u0026gt;A: Almost complete loss of infectivity. No effect on transport of GP to the cell surface and incorporation onto virions. \/evidence=ECO:0000269|PubMed:10482652., P-\u0026gt;R: Almost complete loss of infectivity. No effect on transport of GP to the cell surface and incorporation onto virions. \/evidence=ECO:0000269|PubMed:10482652., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0007829|PDB:6HS4., I -\u0026gt; T., \/evidence=ECO:0007829|PDB:6HS4., \/evidence=ECO:0000255., C-\u0026gt;S: Induces GP1 secretion. Complete loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., heptad repeat 1-heptad repeat 2 region of the transmembrane subunit of Filoviridae viruses, Ebola virus and Marburg virus, and related domains; cd09850, homotrimer interface [polypeptide binding], HR1-GP1 interface [polypeptide binding], HR1A, \/evidence=ECO:0007829|PDB:2EBO., N-\u0026gt;D: Reduced levels of expression of GP, GP1 and GP2. 20% loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., HR1B, HR1C, HR1D, Cl binding site [ion binding], immunosuppressive region, \/evidence=ECO:0007829|PDB:2EBO., \/evidence=ECO:0007829|PDB:2EBO., \/evidence=ECO:0000269|PubMed:12438572., CX(6,7)C motif, C-\u0026gt;S: Induces GP1 secretion. Complete loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., \/evidence=ECO:0007829|PDB:2EBO., C-\u0026gt;G: Induces GP1 secretion. Complete loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., C-\u0026gt;G: Induces GP1 secretion. Complete loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., \/evidence=ECO:0000255., \/evidence=ECO:0007829|PDB:2EBO., HR2, N-\u0026gt;D: Slightly reduced levels of expression of GP1 and GP2. No loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:12438572., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., D-\u0026gt;V: No effect on release of soluble GP1,2delta. \/evidence=ECO:0000269|PubMed:15103332., K-\u0026gt;R,V: No effect on release of soluble GP1,2delta. \/evidence=ECO:0000269|PubMed:15103332., T-\u0026gt;I: 50% loss of release of soluble GP1,2delta. \/evidence=ECO:0000269|PubMed:15103332., L-\u0026gt;V: 60% loss of release of soluble GP1,2delta. \/evidence=ECO:0000269|PubMed:15103332., L-\u0026gt;V: Increased GP shedding. \/evidence=ECO:0000269|PubMed:26092855., P-\u0026gt;A: 60% loss of release of soluble GP1,2delta., Cleavage; by host ADAM17. \/evidence=ECO:0000269|PubMed:15103332., D-\u0026gt;E: No effect on release of soluble GP1,2delta. \/evidence=ECO:0000269|PubMed:15103332., D-\u0026gt;L,V: Increased release of soluble GP1,2delta. \/evidence=ECO:0000269|PubMed:15103332., D-\u0026gt;V: Decreased GP shedding. \/evidence=ECO:0000269|PubMed:26092855., Q-\u0026gt;V: No effect on release of soluble GP1,2delta. \/evidence=ECO:0000269|PubMed:15103332., G-\u0026gt;V: 40% loss of release of soluble GP1,2delta. \/evidence=ECO:0000269|PubMed:15103332., D-\u0026gt;V: No effect on release of soluble GP1,2delta. \/evidence=ECO:0000269|PubMed:15103332., N-\u0026gt;A: No effect on release of soluble GP1,2delta. \/evidence=ECO:0000269|PubMed:15103332., D-\u0026gt;V: No effect on release of soluble GP1,2delta. \/evidence=ECO:0000269|PubMed:15103332., N-\u0026gt;A: No effect on release of soluble GP1,2delta. \/evidence=ECO:0000269|PubMed:15103332., Helical. \/evidence=ECO:0000255., Important role for host BST2\/tetherin antagonism. \/evidence=ECO:0000269|PubMed:27707924., G-\u0026gt;L: About 60% loss of viral release; when associated with L-664. \/evidence=ECO:0000269|PubMed:29669839., A-\u0026gt;L: About 60% loss of viral release; when associated with L-660. \/evidence=ECO:0000269|PubMed:29669839., C-\u0026gt;A: Reduced palmitoylation. No effect on GP processing and association with retrovirus particle. No loss of virus capability to enter into host cell. Loss of localization to the rafts; when associated with A-670. \/evidence=ECO:0000269|PubMed:11152533, ECO:0000269|PubMed:11877482, ECO:0000269|PubMed:12438572., C-\u0026gt;F: Slightly reduced levels of expression of GP1 and GP2. Greatly reduced GP processing and association with retrovirus particle. 43% loss of virus capability to enter into host cell. Loss of localization to the rafts; when associated with A-672. \/evidence=ECO:0000269|PubMed:11152533, ECO:0000269|PubMed:11877482, ECO:0000269|PubMed:12438572., S-palmitoyl cysteine; by host. \/evidence=ECO:0000269|PubMed:11152533., Cytoplasmic. \/evidence=ECO:0000255., C-\u0026gt;A: Reduced palmitoylation. No effect on GP processing and association with retrovirus particle. No loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:11152533, ECO:0000269|PubMed:12438572., C-\u0026gt;F: Slightly reduced levels of expression of GP1 and GP2. Almost no effect on GP processing and association with retrovirus particle. 24% loss of virus capability to enter into host cell. \/evidence=ECO:0000269|PubMed:11152533, ECO:0000269|PubMed:12438572., S-palmitoyl cysteine; by host. \/evidence=ECO:0000269|PubMed:11152533., Nucleocapsid protein; Protein N, Nucleoprotein. \/id=PRO_0000222174., Ebola nucleoprotein; pfam05505, \/evidence=ECO:0000255., Disordered. \/evidence=ECO:0000256|SAM:MobiDB-lite., Acidic residues. \/evidence=ECO:0000256|SAM:MobiDB-lite., Polar residues. \/evidence=ECO:0000256|SAM:MobiDB-lite., Acidic residues. \/evidence=ECO:0000256|SAM:MobiDB-lite., Polar residues. \/evidence=ECO:0000256|SAM:MobiDB-lite., \/evidence=ECO:0007829|PDB:6U55., \/evidence=ECO:0007829|PDB:6U52., \/evidence=ECO:0007829|PDB:6U52., \/evidence=ECO:0007829|PDB:6U52., \/evidence=ECO:0007829|PDB:6U52., \/evidence=ECO:0007829|PDB:6U52., \/evidence=ECO:0007829|PDB:6U52., \/evidence=ECO:0007829|PDB:6U55., \/evidence=ECO:0007829|PDB:6U55., \/evidence=ECO:0007829|PDB:6U55., \/evidence=ECO:0007829|PDB:6U55., \/evidence=ECO:0007829|PDB:6U52., \/evidence=ECO:0007829|PDB:6U52., GP1,2; Virion spike glycoprotein, Filovirus glycoprotein; pfam01611, \/evidence=ECO:0000250., Envelope glycoprotein. \/evidence=ECO:0000250. \/id=PRO_0000314986., Extracellular. \/evidence=ECO:0000255., GP1. \/evidence=ECO:0000250. \/id=PRO_0000314987., Receptor-binding. \/evidence=ECO:0000250., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., \/evidence=ECO:0007829|PDB:6BP2., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., Disordered. \/evidence=ECO:0000256|SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., Polar residues. \/evidence=ECO:0000256|SAM:MobiDB-lite., Mucin-like region. \/evidence=ECO:0000250., Polar residues. \/evidence=ECO:0000256|SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., Low complexity. \/evidence=ECO:0000256|SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., Polar residues. \/evidence=ECO:0000256|SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., Polar residues. \/evidence=ECO:0000256|SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., Low complexity. \/evidence=ECO:0000256|SAM:MobiDB-lite., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., Cleavage; by host furin. \/evidence=ECO:0000250., GP2. \/evidence=ECO:0000250. \/id=PRO_0000314988., \/evidence=ECO:0007829|PDB:6BP2., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., Fusion peptide. \/evidence=ECO:0000250., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., \/evidence=ECO:0007829|PDB:6BP2., heptad repeat 1-heptad repeat 2 region of the transmembrane subunit of Filoviridae viruses, Ebola virus and Marburg virus, and related domains; cd09850, homotrimer interface [polypeptide binding], HR1-GP1 interface [polypeptide binding], HR1A, N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., HR1B, HR1C, HR1D, Cl binding site [ion binding], immunosuppressive region, \/evidence=ECO:0007829|PDB:6BP2., CX(6,7)C motif, \/evidence=ECO:0007829|PDB:6BP2., HR2, N-linked (GlcNAc...) asparagine; by host. \/evidence=ECO:0000255., Helical. \/evidence=ECO:0000255., Cytoplasmic. \/evidence=ECO:0000255., S-palmitoyl cysteine; by host. \/evidence=ECO:0000250|UniProtKB:P35253., S-palmitoyl cysteine; by host. \/evidence=ECO:0000250|UniProtKB:P35253.\u003c\/p\u003e\u003cp\u003e\u003cb\u003ePurification\u003c\/b\u003e:Protein A\/G purified from cell culture supernatant.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eEndotoxin level\u003c\/b\u003e:Please contact us for this information.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eAccession\u003c\/b\u003e:Q05320, Q9QP77, Q1PDC7\u003c\/p\u003e\u003cp\u003e\u003cb\u003eStability and Storage\u003c\/b\u003e:Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.\u003c\/p\u003e\u003cp\u003e\u003cb\u003eClone ID\u003c\/b\u003e:m21D10\u003c\/p\u003e\u003cp\u003e\u003cb\u003eProduct Usage Information\u003c\/b\u003e:ELISA: 1:2000-1:20000; WB: 1:500-1:2000\u003c\/p\u003e\u003cp\u003e\u003cb\u003ePredicted molecular weight\u003c\/b\u003e:\u003c\/p\u003e\u003cp\u003e\u003cb\u003eNote\u003c\/b\u003e:For research use only\u003c\/p\u003e","brand":"GeneBio Systems","offers":[{"title":"Default Title","offer_id":48672897302628,"sku":"VK125013","price":97900.0,"currency_code":"JPY","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0558\/8588\/9636\/files\/no_image_default_image-jpeg_380b4aa6-ff25-4a3c-8eaf-ffa5d04126e9.jpg?v=1782938414","url":"https:\/\/www.genebiosystems.com\/en-jp\/products\/anti-pan-filovirus-gp-envelope-glycoprotein-recombinant-antibody-m21d10","provider":"GeneBio ","version":"1.0","type":"link"}